# AbbVie Agrees to Pay Up to $2.54 Billion in DISCO Pharmaceuticals Collaboration

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/61182
Published: 2026-11-19T07:36:49.000Z
Updated: 2026-11-19T07:36:49.000Z
Section: Business

> The companies will collaborate on developing novel cancer treatments, expanding AbbVie’s work in next-generation therapies.

AbbVie agreed to pay up to $2.54 billion to collaborate with Germany-based DISCO Pharmaceuticals on developing novel cancer treatments, expanding the drugmaker’s work in next-generation therapies.

The collaboration concerns novel cancer treatments.


